Cargando…
Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751690/ https://www.ncbi.nlm.nih.gov/pubmed/36531890 http://dx.doi.org/10.1016/j.ekir.2022.08.030 |
| _version_ | 1784850533383667712 |
|---|---|
| author | Wang, Qiyu Strohbehn, Ian A. Zhao, Sophia Seethapathy, Harish Strohbehn, Samuel D. Hanna, Paul Lee, Meghan Fadden, Riley Sullivan, Ryan J. Boland, Genevieve M. Reynolds, Kerry L. Sise, Meghan E. |
| author_facet | Wang, Qiyu Strohbehn, Ian A. Zhao, Sophia Seethapathy, Harish Strohbehn, Samuel D. Hanna, Paul Lee, Meghan Fadden, Riley Sullivan, Ryan J. Boland, Genevieve M. Reynolds, Kerry L. Sise, Meghan E. |
| author_sort | Wang, Qiyu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9751690 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97516902022-12-16 Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma Wang, Qiyu Strohbehn, Ian A. Zhao, Sophia Seethapathy, Harish Strohbehn, Samuel D. Hanna, Paul Lee, Meghan Fadden, Riley Sullivan, Ryan J. Boland, Genevieve M. Reynolds, Kerry L. Sise, Meghan E. Kidney Int Rep Research Letter Elsevier 2022-09-08 /pmc/articles/PMC9751690/ /pubmed/36531890 http://dx.doi.org/10.1016/j.ekir.2022.08.030 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Research Letter Wang, Qiyu Strohbehn, Ian A. Zhao, Sophia Seethapathy, Harish Strohbehn, Samuel D. Hanna, Paul Lee, Meghan Fadden, Riley Sullivan, Ryan J. Boland, Genevieve M. Reynolds, Kerry L. Sise, Meghan E. Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma |
| title | Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma |
| title_full | Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma |
| title_fullStr | Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma |
| title_full_unstemmed | Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma |
| title_short | Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma |
| title_sort | effect of cancer stage on adverse kidney outcomes in patients receiving immune checkpoint inhibitors for melanoma |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751690/ https://www.ncbi.nlm.nih.gov/pubmed/36531890 http://dx.doi.org/10.1016/j.ekir.2022.08.030 |
| work_keys_str_mv | AT wangqiyu effectofcancerstageonadversekidneyoutcomesinpatientsreceivingimmunecheckpointinhibitorsformelanoma AT strohbehniana effectofcancerstageonadversekidneyoutcomesinpatientsreceivingimmunecheckpointinhibitorsformelanoma AT zhaosophia effectofcancerstageonadversekidneyoutcomesinpatientsreceivingimmunecheckpointinhibitorsformelanoma AT seethapathyharish effectofcancerstageonadversekidneyoutcomesinpatientsreceivingimmunecheckpointinhibitorsformelanoma AT strohbehnsamueld effectofcancerstageonadversekidneyoutcomesinpatientsreceivingimmunecheckpointinhibitorsformelanoma AT hannapaul effectofcancerstageonadversekidneyoutcomesinpatientsreceivingimmunecheckpointinhibitorsformelanoma AT leemeghan effectofcancerstageonadversekidneyoutcomesinpatientsreceivingimmunecheckpointinhibitorsformelanoma AT faddenriley effectofcancerstageonadversekidneyoutcomesinpatientsreceivingimmunecheckpointinhibitorsformelanoma AT sullivanryanj effectofcancerstageonadversekidneyoutcomesinpatientsreceivingimmunecheckpointinhibitorsformelanoma AT bolandgenevievem effectofcancerstageonadversekidneyoutcomesinpatientsreceivingimmunecheckpointinhibitorsformelanoma AT reynoldskerryl effectofcancerstageonadversekidneyoutcomesinpatientsreceivingimmunecheckpointinhibitorsformelanoma AT sisemeghane effectofcancerstageonadversekidneyoutcomesinpatientsreceivingimmunecheckpointinhibitorsformelanoma |